|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-10
|
$13,680
|
$2,599
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Participation in the Eastern Cooperative Oncology Group
|
7U10CA107868-11
|
$160,010
|
$30,402
|
AISNER, JOSEPH
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIA BC 010624
|
$238,703
|
$71,611
|
Ambs, Stefan
|
CCR (NCI)
|
|
T Cell Alternative p38 Activation Pathway
|
ZIA BC 010774
|
$263,161
|
$65,790
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Eastern Cooperative Oncology Group Studies
|
3U10CA014548-38S1
|
$334,918
|
$63,634
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority-Based Community Clinical Oncology Program
|
2U10CA052667-23
|
$573,647
|
$17,209
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-19
|
$3,402,629
|
$340,263
|
BARLOGIE, BART
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Iowa Oncology Research Association
|
5U10CA035101-28
|
$747,553
|
$7,476
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
ECOG Clinical Trials
|
5U10CA017145-38
|
$362,638
|
$68,901
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-25
|
$291,047
|
$55,299
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,557,725
|
$255,772
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Eastern Cooperative Oncology Group
|
3U10CA080775-14S1
|
$43,980
|
$8,356
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group Operations Office
|
3U10CA021115-38S1
|
$139,560
|
$26,516
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
Eastern Cooperative Oncology Group Operations Office
|
5U10CA021115-39
|
$9,389,476
|
$1,784,000
|
COMIS, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
ECOG - ACRIN CCOP RESEARCH BASE GRANT - CORE
|
5U10CA037403-28
|
$3,503,729
|
$350,373
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Eastern Cooperative Group Chair's Office
|
5U10CA086802-15
|
$524,501
|
$99,655
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-06
|
$1,463,426
|
$43,903
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Community Clinical Oncology Program
|
5U10CA035431-30
|
$2,126,787
|
$42,536
|
DAKHIL, SHAKER
|
VIA CHRISTI REGIONAL MEDICAL CENTER
|
|
Main Line Health CCOP
|
5U10CA063847-20
|
$414,235
|
$8,285
|
DeNittis, Albert
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
|
Nevada Cancer Research foundation-Community Clinical Oncology Program
|
5U10CA035421-30
|
$427,060
|
$4,271
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Quality Assurance Review Center
|
3U10CA029511-33S1
|
$1,946,959
|
$38,939
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA016116-40
|
$227,541
|
$43,233
|
FORASTIERE, ARLENE
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of diet and obesity with liver cancer
|
ZIA CP010127-10574
|
$58,496
|
$2,925
|
Freedman, Neal
|
DCEG (NCI)
|
|
Ochsner Community Clinical Oncology Program
|
5U10CA035272-29
|
$563,756
|
$5,638
|
Fuloria, Jyotsna
|
OCHSNER CLINIC FOUNDATION
|
|
GHSU Minority-Based Community Clinical Oncology Program
|
5U10CA107586-10
|
$480,324
|
$9,606
|
Ghamande, Sharad
|
GEORGIA REGENTS UNIVERSITY
|
|
Eastern Cooperative Oncology Group
|
5U10CA027525-35
|
|
$0
|
GOLDSTEIN, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Eastern Cooperative Oncology Group
|
7U10CA027525-36
|
$362,721
|
$68,917
|
GOLDSTEIN, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Geisinger Clinical Oncology Program
|
3U10CA035448-29S1
|
$498,395
|
$4,984
|
Gorak, Edward
|
GEISINGER CLINIC
|
|
ECOG Statistical Office
|
5U10CA023318-37
|
$1,894,415
|
$359,939
|
GRAY, ROBERT
|
DANA-FARBER CANCER INST
|
|
ECOG Statistical Office Data Management Grant
|
5U10CA066636-20
|
$2,152,030
|
$408,886
|
GRAY, ROBERT
|
FRONTIER SCI & TECHNOLOGY RSCH FDN, INC
|
|
The connection of innate and adaptive anti-cancer immunity
|
ZIA BC 010970
|
$874,960
|
$699,968
|
Greiner, John
|
CCR (NCI)
|
|
Phase I Trials of Anti-Cancer Agents
|
3U01CA076576-15S1
|
$754,879
|
$83,037
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Community Clinical Oncology Program
|
2U10CA035199-30
|
$363,406
|
$3,634
|
GRINBLATT, DAVID
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
5U10CA045418-27
|
$1,543,934
|
$15,439
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Eastern Cooperative Oncology Group
|
5U10CA013650-41
|
$176,112
|
$33,461
|
habermann, thomas
|
MAYO CLINIC ROCHESTER
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$584,855
|
$175,456
|
Hakim, Frances
|
CCR (NCI)
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$1,694
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
Activating robust immunity to tumor-associated antigens:mechanisms and biology
|
5R01CA138617-05
|
$283,799
|
$283,799
|
Janssen, Edith
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-12
|
$755,168
|
$7,552
|
Jaslowski, Anthony
|
ST. VINCENT HOSPITAL
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
|
5U10CA021076-38
|
$496,942
|
$94,419
|
Kahl, Brad
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Modulation of IFN action via novel regulatory factors
|
5R01CA078282-14
|
$300,541
|
$300,541
|
KALVAKOLANU, DHAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Eastern Cooperative Oncology Group (Main Institution)
|
5U10CA039229-28
|
$200,536
|
$38,102
|
Kirkwood, John
|
UNIVERSITY OF PITTSBURGH
|
|
Chile Gallbladder Cancer Study
|
ZIA CP010218-10540
|
$322,962
|
$129,185
|
Koshiol, Jill
|
DCEG (NCI)
|
|
Columbus Community Clinical Oncology Program (Columbus CCOP)
|
5U10CA035261-30
|
$733,151
|
$14,663
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
EORTC HEADQUARTERS
|
4U10CA011488-43
|
$250,025
|
$5,001
|
Lacombe, Denis
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Stroger Hospital of Cook County, MBCCOP
|
5U10CA095867-11
|
$743,820
|
$22,315
|
Lad, Thomas
|
HEKTOEN INSTITUTE FOR MEDICAL RESEARCH
|
|
Role of T-bet in the pathogenesis of experimental autoimmune encephalomyelitis
|
ZIA BC 011431
|
$256,398
|
$25,640
|
Lazarevic, Vanja
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA014599-38
|
$4,093,246
|
$40,932
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-38S1
|
$37,500
|
$375
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-38S2
|
$125,000
|
$1,250
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
Total relevant funding to Interferon for this search: $9,068,195
|